Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-15-072515

Chief Executive Officer acquired 14,306 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-09-29 Exercise or conversion : show line 1 in the form +14,306 $7.20 $103,003 70,055 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-09-29 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −14,306 $7.20 2023-05-01 14,306 950,694 D
Loading xslF345X03/doc4.xml…